ResApp Health Ltd. | Mutual Funds
Mutual Funds that own ResApp Health Ltd.
Fidelity Funds SICAV - Pacific Fund
49,573,855
7.52%
-20,694
0.28%
05/31/2018
NEF - Azionario Pacifico
1,861,488
0.28%
0
0.26%
12/31/2017
Fidelity Japan Japan/Asia Growth Equity Mother Fund
1,778,873
0.27%
63,518
0.49%
12/11/2017
SPDR S&P World (ex-US) ETF
1,190,269
0.18%
4,678
0.01%
09/06/2018
SPDR S&P International Small Cap ETF
939,310
0.14%
0
0.02%
09/06/2018
Fidelity Funds SICAV - FAWF Pacific Fund
670,188
0.1%
31,493
0.27%
10/31/2017
Barclays MM Fd. Plc - GlobalAccess Pacific Rim (ex Japan) Fund
245,972
0.04%
19,700
0.03%
11/30/2017
| Address |
127 Creek Street
Brisbane Queensland (QLD) 4000
Australia
|
|
Employees
|
- |
| Website |
http://www.resapphealth.com.au |
| Updated |
07/08/2019 |
| ResApp Health Ltd. engages in the research and commercial development of drugs. It develops smart phone medical applications for the diagnosis and management of respiratory disease. The technology is based on a machine learning algorithm that uses sound alone without the need for additional hardware to diagnose and measure the severity of a respiratory condition. |
